© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to March
fibrinolytic TAFIa carboxypeptidase inhibitor
Ph. II candidate for pulm. embolism; discont.
from literature pharmacophore and SBDD
J. Med. Chem., Mar. 25, 2021
Servier, Croissy-sur-Seine, FR
The Servier thrombin activatable fibrinolysis inhibitor (TAFIa) inhibitor (S62798) is a fibrinolytic (clot degrading) agent which entered Ph. II in the EU for pulmonary embolism, but development appears to have been…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.